← Leaderboards
Hang Lin
University Of Pittsburgh At Pittsburgh
$6,721,334
Attributed
$10,269,758
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.5M · FY2018–25$5M$3.8M$2.5M$1.3M$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,269,758 · 7
By mechanism
UH3$5,697,042 · 2
R01$2,450,812 · 2
UG3$1,541,708 · 1
R21$580,196 · 2
Top collaborators
- Bruce A Bunnell4 shared
- Stuart B Goodman4 shared
- Michael S Gold2 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Sudha Agarwal$4,838,501
- Guoqiang Bi$1,326,746
- Gregg E Homanics$19,295,389
- Thomas Edward Smithgall$26,440,514
- Mark E Schurdak$7,669,687
Others in their field
Other Emerging Leaders on “Cells”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$155,695,588
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Evan Z Macosko · Broad Institute, Inc.$33,096,828
- James Dale Berry · Brigham And Women'S Hospital$30,122,905
- Hanjoon Ryu$28,519,898
- Eric C Palm · Florida State University$26,502,247
Research focus
CellsTissuesJointsIn VitroOsteochondral TissuePharmaceutical PreparationsDegenerative PolyarthritisAdipose TissueSynovial MembraneArthropathiesMacrophagePhenotypeAnimal ModelAnimalsCostIn VivoResponseAffectScreeningClinical TrialsEngineeringPhysiologicalHistologyMediating
Grant awards (12)
Defining the unique capacity of the miniature joint model for investigating the role of adipose tissue and its impacts on osteoarthritis$653,310
R01 · FY2025 · AR · contact PI
Repurposing FDA-approved drugs for the treatment of osteoarthritis using high-throughput screening in microphysiological models$514,092
R01 · FY2025 · AR · contact PI
Defining the unique capacity of the miniature joint model for investigating the role of adipose tissue and its impacts on osteoarthritis$711,760
R01 · FY2024 · AR · contact PI
Repurposing FDA-approved drugs for the treatment of osteoarthritis using high-throughput screening in microphysiological models$571,650
R01 · FY2024 · AR · contact PI
Forskolin-enhanced microfracture to regenerate hyaline cartilage in chondral defect$384,780
R21 · FY2023 · AR · contact PI
Joint Pain on a Chip: Mechanistic Analysis Therapeutic Targets and an Empirical Strategy for Personalized Pain Management$2,287,391
UH3 · FY2021 · TR
Tissue Chip Modeling of Synovial Joint Pathologies: Effects of Inflammation and Adipose-Mediated Diabetic Complications$1,109,539
UH3 · FY2021 · TR · contact PI
Depositing Data Generated from Drug Test on microJoint Model into the Microphysiology Systems Database$77,148
UH3 · FY2021 · TR · contact PI
Tissue Chip Modeling of Synovial Joint Pathologies: Effects of Inflammation and Adipose-Mediated Diabetic Complications$1,099,608
UH3 · FY2020 · TR · contact PI
Joint Pain on a Chip: Mechanistic Analysis Therapeutic Targets and an Empirical Strategy for Personalized Pain Management$1,541,708
UG3 · FY2019 · TR
Tissue Chip Modeling of Synovial Joint Pathologies: Effects of Inflammation and Adipose-Mediated Diabetic Complications$1,123,356
UH3 · FY2019 · TR · contact PI
Regenerative Enhancement of Aged Chondrocytes via Cytoskeletal Modulation$195,416
R21 · FY2018 · AG · contact PI